Millennium Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-278,600
Closed -$28.3M 5901
2025
Q4
$28.3M Buy
278,600
+173,200
+164% +$13.9M 0.01% 1234
2025
Q3
$5.77M Buy
+105,400
New +$5.27M ﹤0.01% 2985
2025
Q2
Sell
-250,000
Closed -$10.8M 5991
2025
Q1
$10.8M Buy
250,000
+151,200
+153% +$7.66M 0.01% 2107
2024
Q4
$5.55M Buy
98,800
+86,900
+730% +$5.41M ﹤0.01% 2727
2024
Q3
$811K Sell
11,900
-18,100
-60% -$1.02M ﹤0.01% 4437
2024
Q2
$1.27M Sell
30,000
-325,000
-92% -$17.9M ﹤0.01% 3921
2024
Q1
$24.5M Buy
355,000
+200,000
+129% +$12.7M 0.01% 1386
2023
Q4
$11.5M Buy
155,000
+34,800
+29% +$2.28M 0.01% 2055
2023
Q3
$8.2M Buy
120,200
+95,200
+381% +$8.08M ﹤0.01% 2235
2023
Q2
$2.35M Buy
25,000
+9,300
+59% +$725K ﹤0.01% 3337
2023
Q1
$1.06M Buy
+15,700
New +$1.01M ﹤0.01% 4034
2022
Q2
Sell
-5,000
Closed -$350K 7111
2022
Q1
$350K Sell
5,000
-45,500
-90% -$3.33M ﹤0.01% 5416
2021
Q4
$3.93M Buy
+50,500
New +$4.46M ﹤0.01% 3139
2021
Q3
Sell
-7,000
Closed -$870K 6909
2021
Q2
$870K Sell
7,000
-13,000
-65% -$1.55M ﹤0.01% 4792
2021
Q1
$2.64M Buy
20,000
+15,000
+300% +$2.05M ﹤0.01% 3261
2020
Q4
$662K Buy
+5,000
New +$605K ﹤0.01% 3995
2020
Q1
Sell
-20,000
Closed -$1.85M 4033
2019
Q4
$1.85M Buy
20,000
+5,000
+33% +$440K ﹤0.01% 2667
2019
Q3
$1.35M Buy
15,000
+10,000
+200% +$1.14M ﹤0.01% 2683
2019
Q2
$590K Sell
5,000
-5,000
-50% -$504K ﹤0.01% 3109
2019
Q1
$866K Buy
10,000
+1,500
+18% +$128K ﹤0.01% 2945
2018
Q4
$536K Sell
8,500
-6,500
-43% -$446K ﹤0.01% 2924
2018
Q3
$1.18M Buy
+15,000
New +$978K ﹤0.01% 2776
2018
Q2
Sell
-80,000
Closed -$3.23M 3885
2018
Q1
$3.23M Buy
+80,000
New +$3.9M ﹤0.01% 2054
2016
Q4
Sell
-158,000
Closed -$2.93M 3442
2016
Q3
$2.93M Buy
+158,000
New +$2.78M ﹤0.01% 1676
2016
Q1
Sell
-610,500
Closed -$5.63M 3377
2015
Q4
$5.63M Buy
+610,500
New +$5.68M 0.01% 1279

Other funds holding EXAS

Millennium Management's EXAS Position: Q1 2026 in Review

Millennium Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,441,516 shares — an estimated $350M sold.

Millennium Management first reported a position in EXAS in Q2 2013 and held it in 44 quarters. The position peaked at $350M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Millennium Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 3,441,516 Exact Sciences shares in Q1 2026, an estimated $350M.
  • Millennium Management first reported a position in Exact Sciences in Q2 2013 and held it in 44 quarters.
  • Millennium Management's Exact Sciences position peaked at $350M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.